Concentrum Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$2.46M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$1.81M |
| 3 |
First Trust NASDAQ-100 Technology Index Fund
QTEC
|
+$1.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$553K |
| 5 |
First Trust Indxx NextG ETF
NXTG
|
+$360K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.28M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$1.96M |
| 3 |
ARK Genomic Revolution ETF
ARKG
|
+$1.23M |
| 4 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$388K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$341K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 49.89% |
| 2 | Technology | 11.65% |
| 3 | Consumer Discretionary | 4.11% |
| 4 | Industrials | 0.74% |
| 5 | Healthcare | 0.28% |
Similar funds
Concentrum Wealth Management's Q2 2020 Portfolio in Review
As of Q2 2020, Concentrum Wealth Management held 44 positions worth $98.6M, up 32% from $74.4M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Concentrum Wealth Management deployed $3.06M of net new capital in Q2 2020, opening 10 new positions and adding to 9 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 15,659 shares worth $2.63M.
By sector, the portfolio is most concentrated in Communication Services at 50% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $4.28M trimmed.
- Concentrum Wealth Management's largest Q2 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 15,659 shares worth $2.63M.
- Concentrum Wealth Management added most to First Trust NASDAQ-100 Technology Index Fund in Q2 2020, an estimated $1.1M increase.
- Concentrum Wealth Management's biggest Q2 2020 reduction was Meta Platforms (Facebook), cutting an estimated $4.28M.
- Concentrum Wealth Management fully exited iShares Biotechnology ETF in Q2 2020, selling an estimated $1.96M.
- Concentrum Wealth Management's ten largest holdings make up 82% of its $98.6M portfolio in Q2 2020.
- Concentrum Wealth Management opened 10 new positions and closed 7 in Q2 2020.
- Concentrum Wealth Management's portfolio value rose 32% quarter-over-quarter to $98.6M.
Based on Concentrum Wealth Management's 13F filing for Q2 2020, filed 6 Aug 2020.